Biologics combination leads to success

Biologics are now established treatment options, particularly for severe courses of the disease. However, there is little data on the the efficacy and safety of simultaneous administration of several biologics for concomitant disease entities. Until now, there has been little knowledge about the combination of mepolizumab and ixekizumab – researchers from Freiburg (Germany) have now investigated this in an individual case.